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Background/Aims: Hypoxia-inducible factor-1α  (HIF- 
1α) is a mediator of tumor progression. Vascular en-
dothelial growth factor (VEGF) is the most potent an-
giogenic factor known to be induced by HIF-1α. We 
investigated the clinicopathological significance of 
HIF-1α and VEGF levels in biopsied gastric cancer 
tissue.  Methods:  Endoscopic biopsy specimens from 
67 patients with gastric carcinoma who underwent sur-
gery were available for this study. Semiquantitative 
RT-PCR was applied to biopsied tumors and normal 
tissues to determine the expressions of HIF-1α and 
VEGF. The expression levels of HIF-1α  and VEGF 
were evaluated using the tumor:normal (T/N) ratios of 
HIF-1α and VEGF mRNA. The clinicopathological var-
iables were reviewed retrospectively. Results:  The T/N 
ratios of HIF-1α mRNA showed significant correlation 
with lymph-node metastases, distant metastases, 
stage, and recurrence within 3 years (p＜0.05). The 
T/N ratios of VEGF mRNA showed significant correla-
tion with lymph-node metastases and distant meta-
stases (p＜0.05). There was a significant correlation 
between the T/N ratios of HIF-1α and VEGF mRNA 
(r=0.72, p＜0.01).  Conclusions:  The increased ex-
pression of HIF-1α  and VEGF mRNA could reflect 
aggressive tumor behavior, including the recurrence of 
gastric cancer. Examination of HIF-1α mRNA in biop-
sy specimens by RT-PCR assay might provide useful 
preoperative information on tumor aggressiveness. 
(Gut and Liver 2009;3:88-94)
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INTRODUCTION
  Altered glucose metabolism and cellular adaptation to 
hypoxia, including increased glycolysis and neovasculari-
zation are fundamental to tumor progression and affect 
tumor characteristics such as proliferation, invasion, 
metastasis, and lethality. In the absence of neovasculari-
zation, the growth of malignant epithelial tumors is lim-
ited because of insufficient oxygen supply due to the ab-
sence of adequate vascular supply to the tumor tissue. 
Hypoxia-inducible factor (HIF)-1α has been recognized 
as a very important mediating molecule for hypoxic adap-
tation and the induction of proliferation and angiogenesis 
in various malignancies.
1-5 
  HIF-1 consists of α and  β subunits. HIF-1β is con-
stitutively expressed, while the expression of HIF-1α is 
tightly regulated by cellular O2. HIF-1α is degraded un-
der normoxic conditions via the ubiquitin-dependent pro-
teosome pathway. However, this pathway is inhibited by 
hypoxia leading to induction and stabilization of the 
HIF-1α. Many investigators have observed that HIF-1α 
mRNA levels increase following prolonged hypoxia.
5-9 The 
stabilized HIF-1α dimerizes with HIF-1β, translocates 
from the cytoplasm into the nucleus and binds to hypo-
xia-responsive elements (HRE) within the nucleus. A 
wide variety of genes encoding vascular endothelial 
growth factor (VEGF), endothelin-1, transferring, eryth-
ropoietin, and inducible nitric oxide synthase are known 
to have HREs and are activated by HIF-1α.
3,6,10,11 These 
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viability, angiogenesis, as well as metabolic adaptation to 
hypoxia.
12,13 
  VEGF is probably the most potent angiogenic factor in-
duced by HIF-1α.
2,11,12,14,15 Many studies have provided 
evidence that VEGF mRNA is not induced by hypoxia in 
HIF-1α-deficient embryonic stem (ES) cells, and dramatic 
vascular regression occurs in HIF-1α-null mouse 
embryos.
12,16 I n  a d d i t i o n ,  h i g h l y  m e t a s t a t i c  l u n g  c a n c e r  
cells have been shown to produce a larger amount of 
VEGF mRNA under hypoxic conditions through con-
stitutive HIF-1α mRNA upregulation compared to cells 
with a low metastatic potential, thereby leading to ex-
tensive neoangiogenesis.
15 One study showed a correlation 
between HIF-1α-induced VEGF expression and the in-
duction of angiogenesis in gastric cancer by a semiquanti-
tative assessment of the formation of blood vessels.
17 
Overexpression of VEGF may be correlated the aggressive 
behavior of malignancies.
2,7,18,19 VEGF also has been re-
ported to function as a vascular permeability factor of tu-
mor vessels, facilitating the extravasation of proteins, and 
the production of ascites and carcinomatosis in gastric 
cancers.
20 
  Most studies have shown that HIF-1α expression is as-
sociated with a poor prognosis in various malig-
nancies.
4,8,11-13,21 However, there are conflicting results in 
studies on gastric cancers. Some studies have shown that 
a high HIF-1α expression was not associated with prog-
nosis,
22,23 whereas others have found that HIF-1α ex-
pression was a prognostic factor associated with a poor 
outcome in gastric cancers.
4,11,12,21 
    The aim of this study was to investigate the clin-
icopathological significance of the level of HIF-1α and 
VEGF mRNA in biopsied gastric cancer tissues. 
MATERIALS AND METHODS 
1. Patients and tissue specimens
  Sixty-seven patients with gastric carcinoma were en-
rolled in this study. All patients underwent a gastrectomy 
procedure in the department of surgery, Ewha Mokdong 
hospital, Seoul, Korea from 2003 to 2004. In addition, an 
upper GI endoscopy was performed before surgery. 
During endoscopy, at least 6 pieces of tissues were biop-
sied from the carcinoma and macroscopically normal mu-
cosa, respectively. At least 4 pieces of the collected speci-
mens were frozen immediately and stored at −70
oC until 
extraction of mRNA to determine the levels of HIF-1α 
and VEGF. Other specimens were fixed in 10% formalin 
and embedded in paraffin for pathology examination with 
hematoxylin and eosin staining. The pathologic diagnoses 
for endoscopically biopsied specimens were matched with 
those of the surgically resected tissues, and a consultant 
pathologist determined the pathologic staging. The clin-
ical and histopathological data from all study patients 
were reviewed. 
  The Human Research Review Committee approved the 
study and informed consent was obtained from all 
patients.
2. Measurements of HIF-1α and VEGF mRNA by 
semiquantitative RT-PCR assay
1) RNA extraction
  Total RNA was extracted from the biopsy tissues using 
the easy-BLUE
TM (iNtRON biotechnology, Seongnam, 
Korea) total RNA extraction kit. Prepared fresh tissues 
were added to 800μL of easy-BLUE
TM reagent and homo-
genized using a homogenizer or equivalent and vigorously 
vortexed at room temperature for 10 sec. Then, 200μL 
chloroform was added and a vortex was applied. After the 
sample was left for 2-3 minutes at room temperature, the 
solution was centrifuged at 12,000 rpm (4
oC) for 10 
minutes. Next, 400μL of the top layer of fluid was trans-
ferred to an empty 1.5 ml tube, and 400μL isopropanol 
(2-propanol) was added to it. We mixed it well by invert-
ing the tube 2-3 times. The sample was then left for 10 
minutes at room temperature. After centrifuging the sol-
ution at 12,000 rpm (4
oC) for 10 minutes, we removed 
the upper layer to obtain the RNA pellet. Next, 1 mL 
75% ETOH was added and the solution was mixed well 
by inverting the tube 2-3 times. The mixture was centri-
fuged for 5 minutes at 12,000 rpm (4
oC). The top layer 
was discarded and the remaining RNA pellet was dried. 
The RNA was dissolved using 20-50μL of DEPC treated 
distilled water for storage at −70
oC. The amount and pu-
rity of the extracted RNA was quantitated by spec-
trophotometry.
2) cDNA synthesis 
  cDNA was synthesized with 5μg of total RNA and oli-
go dT primer. In a sterile RNase-free microcentrifuge 
tube, 0.5μg of oligo dT primer and 5μg RNA sample 
were added. The tube was heated at 70
oC for 5 minutes, 
and cooled immediately on ice. The M-MLV RTase 
(Moloney Murine Leukemia Virus Reverse Transcriptase) 
(Promega, Madison, WI, USA) 200 units, rRNasin ribonu-
clease inhibitor (Promega, Madison, WI, USA) 25 units, 5 
μL 5xRT buffer, and 2 mM dNTP were added to the 
tube, to obtain a 25μL solution using 0.1% DEPC. The 
tube was gently mixed, incubated for 60 minutes at 42
oC, 
and heated for 5 minutes at 95
oC. The cDNA was stored 
at  −20
oC. 90   Gut and Liver, Vol. 3, No. 2, June 2009
Table 1. Clinicopathological Characteristics of the Patients
Variables n (%)
Age (years) Mean±SD (Range) 61±10 (28-84)
Male/Female 41/26
Operation
   Curative resection 57 (85.1)
   Non-curative 10 (14.9)
Differentiation
   Well  9 (13.4)
   Moderatey 25 (37.3)
   Poorly/Signet ring cell  33 (49.3)
Lymphatic invasion
   −/+ 41 (61.2)/26 (38.8)
Venous invasion
   −/+ 49 (73.1)/18 (26.9) 
Depth of invasion
   T1 24 (35.8)
   T2 10 (14.9)
   T3 26 (38.8)
   T4  7 (10.5)
Nodal status
   N0  30 (44.8)
   N1 22 (32.8)
   N 2 5  ( 7 . 5 )
   N3 10 (14.9)
Distant metastasis
   M0 58 (86.6)
   M1  9 (13.4)
Stage
   I 27 (40.3)
   II  8 (11.9)
   III 17 (25.4)
   IV 15 (22.4)
3) Oligonucleotide primers 
  The primers used were 5'-AAG ATG ACC CAG ATC 
ATG TTT GAG-3' and 5'-AGG AGG AGC AAT GAT CTT 
GAT CTT-3' for β-actin, 5'-CCT GCA CTC AAT CAA 
GAA GTT GC-3'and 5'-TTC CTG CTC TGT TTG GTG 
AGG CT-3' for HIF-1α,
25 5'-GCA GAA TCA TCA CGA 
AGT GG-3' and 5'-GCA ACG CGA GTC TGT GTT TTT 
G-3' for VEGF.
26 All primers were synthesized by 
TaKaRaKorea Biomedical Inc.
4) PCR amplification
  The amplification reaction was carried out in the 20μL 
of the PCR mixture containing 4μL of the synthesized 
cDNA solution, 4μL of 5ｘ polymerase reaction buffer, 
200μM of dNTP, 0.5μM of each primer (sense and anti-
sense) and 1 unit of Taq polymerase (Promega, Madison, 
WI, USA). The PCR mixture was amplified using the 
GeneAmp PCR System 9600 (PERKIN-ELMER Corp., 
Norwalk, CT, USA). The amplified PCR products (10μL) 
were identified by electrophoresis on a 1% agarose gel 
containing ethidium bromide and with ultraviolet (UV) 
illumination. The housekeeping gene, β-actin was used 
as a control for the semiquantitative analysis of HIF-1α 
and VEGF. A negative control used H2O instead of 
cDNA. The gene transcripts were quantified based on the 
ratio of the intensity of the target gene to the intensity of 
the  β-actin control gene. 
3. Statistical analysis
  The results were expressed as the mean ± the standard 
deviation. The association between the clinicopathological 
variables and the expression of HIF-1α and VEGF mRNA 
was analyzed using the Student’s t-test, ANOVA test and 
a nonparametric test. The correlation between the ex-
pression of HIF-1α and VEGF mRNA was analyzed by 
the Pearson correlation test. The data were considered 
significant if the p value was ＜0.05. Statistical analyses 
were performed using the SPSS version 11.0 program 
(SPSS Inc., Chicago, IL, USA). 
RESULTS
1. Patients and clinicopathological findings 
    S i x t y - s e v e n  p a t i e n t s  w e r e  e n r o l l e d  i n  t h i s  s t u d y ;  4 1  
were men and 26 were women between the ages of 28 
and 84 (mean, 61 years). The gross pathology findings 
showed 24 cases (36.4%) with early gastric cancer (EGC) 
and 43 cases (63.6%) with advanced gastric cancer 
(AGC). Curative resections were performed in 57 patients 
(85.1%) and 10 (14.9%) underwent non-curative surgical 
procedures. The prognosis of the 67 cancer patients in 
this study was monitored for a median follow-up time of 
34 months (range, 3-46 months). During the observation 
period, 16 patients died from gastric carcinoma and the 
3-year survival rate was 76.1%. Only one patient received 
radiotherapy, and eight patients underwent chemotherapy 
after surgery. 
  The histological differentiation showed that there were 
9 cases of the well-differentiated type (13.4%), 25 cases 
of the moderately-differentiated type (37.3%) and 33 cas-
es of the poorly-differentiated/signet ring cell type 
(49.3%). Involvement of the lymphatic vessels was pres-
ent in 26 cases (38.8%). Vascular invasion was demon-
strated in 18 cases (26.9%). The T staging included 24 
cases (35.8%) that were T1, 10 cases (14.9%) T2, 26 cases 
(38.8%) T3, and 7 cases (10.5%) T4. Nodal involvement 
was identified in 37 cases (55.2%). Distant metastases 
were seen in 9 cases (13.4%). There were 27 cases 
(40.3%), 8 cases (11.9%), 17 cases (25.4%), and 15 cases 
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Fig. 1. Relationship between tumor differentiation and mRNA 
expressions of HIF-1α and VEGF. White bars, well differen-
tiated; black bars, moderately/poorly differentiated. p＞0.05.
Fig. 2. Relationship between lymphatic invasion and mRNA 
expressions of HIF-1α  and VEGF. White bars, lymphatic 
invasion (−); black bars, lymphatic invasion (+). p＞0.05.
Fig. 3. Relationship between vascular invasion and mRNA 
expressions of HIF-1α  and VEGF. White bars, vascular 
invasion (−); black bars, vascular invasion (+). p＞0.05.
Fig. 4. Relationship between nodal metastasis and mRNA 
expressions of HIF-1α  and VEGF. White bars, nodal 
metastasis (−); black bars, nodal metastasis (+). *p＜0.05.
Fig. 5. Relationship between distant metastasis and mRNA 
expressions of HIF-1α and VEGF. White bars, distant metas-
tasis (−); black bars, distant metastasis (+). *p＜0.05.
(Table 1). 
2. Correlation between clinicopathological features 
and the expression of HIF-1α  and VEGF 
mRNAs 
  The up-regulation of HIF-1α mRNA and VEGF mRNA 
were 91% and 75% in the tissue samples, respectively. 
The up- or down-regulation themselves was not asso-
ciated with differentiation, invasion or metastases of the 
cancer. We thus considered it to be appropriate to com-
pare the expression level in tumor samples with that in 
normal samples for each case. The expression of HIF-1α 
and VEGF mRNAs was evaluated using the tumor:normal 
(T/N) ratio of the HIF-1α and VEGF mRNAs. 
  There was a tendency for the T/N ratios of HIF-1α 
mRNAs to correlate with tumor differentiation (p=0.06) 
(Fig. 1). The T/N ratios of HIF-1α mRNA showed no 
significant association with lymphatic and vascular in-
vasion (p=0.75 and p=0.62) (Figs. 2, 3). However, sig-
nificant correlations were noted with lymph node meta-
stases, distant metastases, tumor stage, and tumor re-
currence within 3 years (p＜0.01, p=0.02, p=0.01, and 92   Gut and Liver, Vol. 3, No. 2, June 2009
Fig. 6. Relationship between recurrence within 3 years and 
mRNA expressions of HIF-1α  and VEGF. White bars, 
recurrence (−); black bars, recurrence (+). *p＜0.05.
Fig. 7. Relationship between tumor stage and mRNA expres-
sions of HIF-1α and VEGF. *p for trend ＜0.05.
Fig. 8. Correlation between expressions of HIF-1α and VEGF
mRNA. r=0.72, p＜0.01.
p=0.03, respectively) (Figs. 4-7). The T/N ratios of VEGF 
mRNA did not significantly differ for tumor differ-
entiation (p=0.23) (Fig. 1), the presence of lymphatic in-
vasion (p=0.25) (Fig. 2), or vascular invasion (p=0.23) 
(Fig. 3). However, the T/N ratios of VEGF mRNA 
showed significant correlation with lymph node and dis-
tant metastases (p＜0.01 and p=0.03) (Figs. 4, 5), and 
there was a tendency toward a correlation with the tumor 
stage (p=0.07) (Fig. 7) and tumor recurrence within 3 
years (p=0.07) (Fig. 6). 
3. Correlation between the expression of HIF-1α 
and VEGF mRNAs 
  There was a significant correlation between the T/N ra-
tios of HIF-1α and VEGF mRNA (r=0.72, p＜0.01) (Fig. 
8).
DISCUSSION
  We studied HIF-1α and VEGF expression as a prog-
nostic factor in surgically resected gastric tumors. We ex-
amined the expression level of HIF-1α and VEGF mRNA 
in endoscopically biopsied tissues, and demonstrated that 
they appeared to be associated with the behavior and out-
come of gastric carcinomas.
  Expression of HIF-1α has been evaluated by study of 
the protein levels in most human neoplasms.
1,4,11,24-26 
Until recently, few reports have examined HIF-1α mRNA 
in human gastric carcinoma. However, more recently 
Matsuyama  et al.
26 reported that HIF-1α mRNA corre-
lated with HIF-1α protein levels. Thus, overexpression of 
HIF-1α i n  s o l i d  t u m o r s  h a s  b e e n  c o n f i r m e d  b o t h  a t  t h e 
protein and at the mRNA levels. In prior studies of other 
organs, investigators have demonstrated that HIF-1α 
mRNA was overexpressed in cancer cell lines and that 
the metastatic potential correlated with HIF-1α mRNA 
levels in those cell lines.
8 There have been other reports 
showing that quantitative analysis of VEGF mRNA in 
gastric cancer biopsy specimens might be useful in pre-
dicting metastasis of gastric cancer to the regional lymph 
nodes.
27,28 We measured the levels of HIF-1α mRNA and 
VEGF mRNA, not the protein levels of VEGF and HIF- 
1α. It was a challenge to examine clinical significance in 
gastric cancer with different methods of measurements. 
One limitation of our study is that we did not compare 
the immunohistochemical results of HIF-1α and VEGF 
with the mRNA expression levels. 
  In our study, a positive correlation was observed be-
tween VEGF and HIF-1α mRNAs in gastric carcinoma 
samples (r=0.72, p＜0.01). This result is consistent with 
previous studies that reported that an increased level of 
HIF-1α mRNAs may upregulate VEGF mRNA by aug-
mented transcriptional activity,
13,14,29 as well as significant 
correlation between VEGF and HIF-1α  protein expres-
sion.
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mRNA up-regulation under hypoxic conditions produced 
a large amount of VEGF, especially in highly metastastic 
lung cancer cell lines.
15 HIF-1α  activates the tran-
scription of VEGF, which mediates angiogenesis when se-
creted by tumor cells. Thus, enhancement of angiogenesis 
by hypoxia is a prerequisite for the progressive growth of 
gastric carcinomas.
12 
  Most studies have shown HIF-1α expression is asso-
ciated with a poor prognosis.
1,23,30,31 However, some stud-
ies have found that a high HIF-1α expression was asso-
ciated with an improved prognosis in some tumors, in-
cluding those of the head and neck, cervical cancer, non- 
small cell carcinoma of the lung, and ovarian cancer.
23,32 
Studies on the expression of HIF-1α have also been con-
flicting for gastrointestinal malignancies. Some reports 
have shown that HIF-1α expression was an adverse prog-
nostic factor in gastrointestinal stromal tumors and gas-
tric cancers.
4,11-13,21,24 HIF-1α was associated with poor 
clinicopathological features, VEGF expression and micro-
vessel invasion.
12 The combination of a HIF-1α protein 
overexpression with nonfunctional p53 tends to indicate a 
dismal prognosis.
21 By contrast, others have suggested 
that HIF-1α expression (positive vs. negative) has no 
statistically significant relationship with clinicopatho-
logical features such as tumor differentiation, Lauren type 
and the TNM stage of gastric cancers.
22,23 
  The reasons for these different prognostic outcomes ob-
served in numerous studies are not clear. Some inves-
tigators suggested cautiously that cancer progression 
might be regulated differentially by HIF-1α of a range of 
downstream target molecules.
5,23 They said that this dif-
ferential regulation might also be determined by different 
physiological processes, such as hypoxia, the presence of 
an oncogene, or other homologues of the HIF family 
(HIF-2α or HIF-3α), leading to HIF-1α stabilization in 
individual tumors.
5,23,24,29 
  The results of our study, measuring the level of HIF- 
1α mRNA in gastric cancer, are consistent with other 
studies showing that the overexpression of HIF-1α was 
correlated with the pathogenesis of cancer development, 
progression and the loss of differentiation.
1,2,25,30 The sig-
nificant correlation between the level of HIF-1α mRNAs 
and tumor stage was also founded in our study. Although 
Fig. 7 showed that the T/N ratios of HIF-1α mRNA de-
creased in stage II, compared with in stage I, there was 
no statistically significant difference between the levels in 
both stages. 
  VEGF might be a significant prognostic factor; it is di-
rectly associated with the production of ascites and the 
peritoneal dissemination of gastric cancer.
20 Some studies 
have shown that the overexpression of VEGF protein cor-
relates with tumor progression and a poor clinical out-
come including high lymphatic vessel density in various 
cancers and in gastric cancer.
1,7,33-35 
  Our data showed that the level of HIF-1α and VEGF 
mRNA was significantly higher in patients with a cancer 
recurrence within three years of the initial diagnosis. 
Therefore, the semiquantitative RT-PCR assay for HIF-1α 
and VEGF might be used to predict the recurrence of gas-
tric cancer within a short time interval.
  Some investigators have demonstrated that HIF-1α ac-
tivity could be observed in nearly all of cancer specimens; 
this is consistent with our findings (positive in 91% of 
cancer specimens). In addition, HIF-1α activity has been 
identified in most precancerous lesions such as colon ad-
enomas, breast ductal carcinoma in situ and prostate intra-
epithelial neoplasia. By contrast, every benign noninvasive 
tumor analyzed was negative for HIF-1α  overexpres-
sion.
25,26 Thus, increased expression of HIF-1α and VEGF 
mRNA may be specific markers for treatment and/or clin-
ical surveillance of patients, representing very early events 
in carcinogenesis prior to detection of histological evi-
dence of angiogenesis or invasion.
23,25,36 
  The results of this study suggest that the increased lev-
els of HIF-1α and VEGF mRNA may play an important 
role in tumor progression of gastric carcinomas. Gastric 
carcinomas that express HIF-1α and VEGF may continue 
to grow by various adaptive responses such as neoangio-
genesis. Examination of HIF-1α m R N A  i n  b i o p s y  s p e c i -
mens, by the semiquantitative RT-PCR assay, may pro-
vide useful preoperative information on tumor aggressive-
ness.
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